Table 1.
Total (N=30) | Arm 1 (N=15) | Arm 2 (N=15) | P value | |
---|---|---|---|---|
Age, Median Year (range) | 0.77 | |||
Median | 62 (44-77) | 63 (44-73) | 62 (49-77) | |
Sex, N (%) | >0.99 | |||
Male | 21 (70) | 11 (73) | 10 (67) | |
Female | 9 (30) | 4 (27) | 5 (33) | |
ECOG, N (%) | 0.70 | |||
0 | 10 (33) | 6 (40) | 4 (27) | |
1 | 20 (67) | 9 (60) | 11 (73) | |
Prior Chemotherapy Regimens, N (%) | 0.017 | |||
1 | 6 (20) | 6 (40) | 0 (0) | |
2 | 10 (33) | 4 (27) | 6 (40) | |
3 | 12 (40) | 4 (27) | 8 (53) | |
4 | 2 (7) | 1 (7) | 1 (7) | |
Metastatic Sites, N (%) | >0.99 | |||
0* | 4 (13) | 2 (13) | 2 (13) | |
1 | 6 (20) | 3 (20) | 3 (20) | |
2+ | 20 (67) | 10 (67) | 10 (67) |
(Locally Advanced, Recurrent)